Lymphoma Research Foundation Elects New Scientific Advisory Board Members

Foundation welcomes four world-leading lymphoma experts to contribute to the global impact of the Foundation and guide the Foundation’s research portfolio

The Lymphoma Research Foundation is proud to welcome four new members to its elite Scientific Advisory Board (SAB):

Alex Herrera, MD
Chief, Division of Lymphoma, Department of Hematology and Hematopoietic Cell Transplantation
City of Hope

Kami Maddocks, MD
Lymphoma Program Director
The Ohio State University

Todd Fehniger, MD, PhD
Professor of Medicine, Division of Oncology
Washington University in St. Louis

Gilles Salles, MD, PhD
Chief, Lymphoma Service and Steven A. Greenberg Chair
Memorial Sloan Kettering Cancer Center

Comprised of 45 world-renowned lymphoma experts, the Lymphoma Research Foundation’s SAB seeks out the most innovative and promising lymphoma research projects for support.  Members of the Foundation’s SAB are leaders in blood cancer research, with unparalleled experience and accomplishments in both lymphoma-specific research and clinical care. They guide the planning of the Foundation’s research portfolio, selecting and monitoring grant recipients and designing the Foundation’s international consortia and scientific programs.

“We are thrilled to welcome these new members to the Scientific Advisory Board, and I look forward to seeing what we can accomplish together,” said Ann LaCasce, MD chair of the Scientific Advisory Board. “Our new members bring unique expertise and will be instrumental in helping us advance the Foundation’s mission to realize the promise of science to eradicate lymphoma and serve the community touched by this disease.”

The new SAB members will assume their role on July 1, 2024, in accordance with the SAB’s governing principles and standards. They will join members to review grant proposals, make recommendations regarding research priorities and funding to the Foundation’s Board of Directors, evaluate the progress of ongoing research projects, and guide the strategic direction of the Foundation’s research programs and consortia.

“At the Lymphoma Research Foundation, everything we do begins with scientific research and insights from the world’s leading experts, which is why the Scientific Advisory Board is so critical,” said Meghan Gutierrez, CEO of the Lymphoma Research Foundation. “With the incredible leaders on our Scientific Advisory Board, I am confident that a future without this disease is within our reach.”